These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 31783290)
1. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. Ibrahim EY; Ehrlich BE Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290 [TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy-induced peripheral neuropathy]. Noguchi E; Maeda Y Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183 [TBL] [Abstract][Full Text] [Related]
3. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview. Chan A; Hertz DL; Morales M; Adams EJ; Gordon S; Tan CJ; Staff NP; Kamath J; Oh J; Shinde S; Pon D; Dixit N; D'Olimpio J; Dumitrescu C; Gobbo M; Kober K; Mayo S; Pang L; Subbiah I; Beutler AS; Peters KB; Loprinzi C; Lustberg MB Support Care Cancer; 2019 Oct; 27(10):3729-3737. PubMed ID: 31363906 [TBL] [Abstract][Full Text] [Related]
4. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review. Chu SH; Lee YJ; Lee ES; Geng Y; Wang XS; Cleeland CS Support Care Cancer; 2015 Feb; 23(2):513-24. PubMed ID: 25256375 [TBL] [Abstract][Full Text] [Related]
8. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis. Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888 [TBL] [Abstract][Full Text] [Related]
9. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP. Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888 [TBL] [Abstract][Full Text] [Related]
10. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial. Clavo B; Martínez-Sánchez G; Rodríguez-Esparragón F; Rodríguez-Abreu D; Galván S; Aguiar-Bujanda D; Díaz-Garrido JA; Cañas S; Torres-Mata LB; Fabelo H; Téllez T; Santana-Rodríguez N; Fernández-Pérez L; Marrero-Callico G Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802143 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Ewertz M; Qvortrup C; Eckhoff L Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757 [TBL] [Abstract][Full Text] [Related]
12. Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database. Inoue M; Matsumoto K; Tanaka M; Yoshida Y; Satake R; Goto F; Shimada K; Mukai R; Hasegawa S; Suzuki T; Ikesue H; Liao J; Hashida T; Nakamura M Sci Rep; 2021 May; 11(1):11324. PubMed ID: 34059747 [TBL] [Abstract][Full Text] [Related]
13. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy. Bakogeorgos M; Georgoulias V Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced neuropathy: A comprehensive survey. Miltenburg NC; Boogerd W Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939 [TBL] [Abstract][Full Text] [Related]
15. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Burgess J; Ferdousi M; Gosal D; Boon C; Matsumoto K; Marshall A; Mak T; Marshall A; Frank B; Malik RA; Alam U Oncol Ther; 2021 Dec; 9(2):385-450. PubMed ID: 34655433 [TBL] [Abstract][Full Text] [Related]
17. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics. Hopkins HL; Duggett NA; Flatters SJL Curr Opin Support Palliat Care; 2016 Jun; 10(2):119-128. PubMed ID: 27054288 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity. Sałat K Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537 [TBL] [Abstract][Full Text] [Related]